NDC 0641-6022-01 - Famotidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6022
- Requested NDC
- 0641-6022-01
- Package NDCs from labels
- 0641-6022-01, 0641-6022-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Famotidine Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Famotidine - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6022-01 | Famotidine | 2 mL in 1 VIAL | INJECTION | 2 | 9 | |
| 0641-6022-25 | Famotidine | 25 in 1 CARTON | INJECTION | 25 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6022-01 | ML - Milliliter | 0641-6022 | 14529626-4b70-42c6-a890-9b69073ec03a | 1 | 2013-02-13 |
| 0641-6022-25 | ML - Milliliter | 0641-6022 | 4387b354-0e9e-4478-9b06-72f87bf78c58 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACID CONTROLLER | FAMOTIDINE | Safeway | 9ddfb9fd-1b84-4e9a-90b5-6a3362d345dd | 2025-08-13 | Warnings | 5QZO15J2Z8 |
| UP AND UP DUAL ACTION ACID REDUCER ANTACID | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | Target Corporation | 8e925e57-9036-4658-bf07-578e22675af8 | 2025-08-11 | Warnings | 5QZO15J2Z8 |
| Acid Reducer Plus Antacid | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | CVS Pharmacy | d6f0b82c-3890-4e85-8b8a-354fb8d0b640 | 2025-08-11 | Warnings | 5QZO15J2Z8 |
| Acid Reducer Plus Antacid | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | CVS Pharmacy | 509435e4-14fd-4e09-bdc1-ad295b46806b | 2025-08-11 | Warnings | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Ascend Laboratories, LLC | be69d9f9-f4ad-4cfe-bab2-e07186b25c1e | 2025-08-07 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| acid controller | FAMOTIDINE | Safeway | f3d08f06-a676-43b0-8f77-611f0af737a7 | 2025-08-07 | Warnings | 5QZO15J2Z8 |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Preferred Pharmaceuticals Inc. | e2f29ca9-9ec8-4b82-8c80-8628d9e3ab2f | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Micro Labs Limited | 1756ab7d-05c4-4726-8f72-4e8363440968 | 2025-07-29 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Welmate Famotidine 20mg | FAMOTIDINE 20MG | YYBA Corp | 1ea3c6b6-4c1e-d93c-e063-6394a90a0dac | 2025-07-29 | Warnings | 5QZO15J2Z8 |
| Welmate Famotidine 10mg | FAMOTIDINE 10MG | YYBA Corp | 1e19d0cc-65d7-8ec4-e063-6394a90a3d2a | 2025-07-29 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Chain Drug Marketing Association INC | 7fbc5e10-30c6-7f8d-1040-d48a80fe4d79 | 2025-07-22 | Warnings | 5QZO15J2Z8 |
| Acid Reducer Original Strength | FAMOTIDINE | Dr.Reddys Laboratories Inc. | ca039876-f7e5-3e60-da5a-a1f40637a417 | 2025-07-17 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Albertsons Companies | 27314f55-5e31-703c-b98c-ec89bf308472 | 2025-07-17 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Family Dollar Stores, Inc. | 0f81e8ac-ddad-13d6-e883-6a5310e058de | 2025-07-17 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Discount Drug Mart, Inc | c5d81352-c45b-3ea1-9974-8a096bd05009 | 2025-07-17 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Chain Drug Consortium, LLC | 937f7bce-955b-9418-5aed-2e84aee50de3 | 2025-07-17 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Chain Drug Marketing Association INC | 1d78bc9e-cf7b-8853-c6dc-b36e5de4dd0a | 2025-07-17 | Warnings | 5QZO15J2Z8 |
| equate famotidine | FAMOTIDINE | WALMART INC. | f38f8a8f-3292-4fe5-b83f-ffd634196d42 | 2025-07-16 | Warnings | 5QZO15J2Z8 |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | PHOENIX RX LLC | 397f1f23-10c2-569e-e063-6394a90a7164 | 2025-07-11 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.